Genomic cloning and protein expression of a novel rat brain cytochrome P-450 CYP2D18 catalyzing imipramine N-demethylation

被引:47
作者
Kawashima, H
Sequeira, DJ
Nelson, DR
Strobel, HW
机构
[1] UNIV TEXAS,SCH MED,DEPT BIOCHEM & MOL BIOL,HOUSTON,TX 77225
[2] UNIV TENNESSEE,DEPT BIOCHEM,MEMPHIS,TN 38163
关键词
D O I
10.1074/jbc.271.45.28176
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have previously reported the isolation of two cDNA clones, designated 2d-29 and 2d-35, which have identical open reading frames and code for a novel brain cytochrome P-450 (P-450) belonging to the CYP2D subfamily, and noted that the mRNA of clone 2d-35 seems to be expressed in the brain but not in the liver (1). Although the deduced amino acid sequence of these clones differs from that of the liver CYP2D4 by only 5 amino acids distributed in the C-terminal region, this new P-450 cDNA clone contained st unique 5'-extension, and we posit in this report by analysis of a genomic clone that this 5'-untranslated sequence is derived from a gene distinct from that of CYP2D4. Thus, this novel P-450 was named P-450 2D18 according to the recommended nomenclature (2), The expressibility of this cDNA was confirmed by in vitro translation using a reticulocyte system, and protein expression was performed using COS-M6 cells. Immunoblot analysis showed a cross-reacting band of the predicted size range with anti-P-450 2D6 antiserum, which was not seen in control cells. Furthermore, the CYP2D18-expressed COS cell lysate showed N-demethylation activity toward imipramine, whereas another brain P-450 CYP4F6-expressed COS cell lysate showed 10-hydroxylation activity. This is the first report that associates an individual P-450 isozyme in brain with a particular metabolic alteration of the antidepressant imipramine.
引用
收藏
页码:28176 / 28180
页数:5
相关论文
共 29 条
[1]  
Ausubel FM., 1993, Current Protocols in Molecular Biology
[2]  
BARBEAU A, 1985, LANCET, V2, P1213
[3]   RECONSTITUTION OF THE BRAIN MIXED-FUNCTION OXIDASE SYSTEM - PURIFICATION OF NADPH-CYTOCHROME-P450 REDUCTASE AND PARTIAL-PURIFICATION OF CYTOCHROME-P450 FROM WHOLE RAT-BRAIN [J].
BERGH, AF ;
STROBEL, HW .
JOURNAL OF NEUROCHEMISTRY, 1992, 59 (02) :575-581
[4]   ROLE OF P450IID6, THE TARGET OF THE SPARTEINE-DEBRISOQUIN OXIDATION POLYMORPHISM, IN THE METABOLISM OF IMIPRAMINE [J].
BROSEN, K ;
ZEUGIN, T ;
MEYER, UA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (06) :609-617
[5]   IDENTIFICATION OF CYTOCHROMES-P450 CYTOCHROMES-1A2, CYTOCHROMES-2A1, CYTOCHROMES-2C7, CYTOCHROMES-2E1 IN RAT GLIOMA C6 CELL-LINE BY RT-PCR AND SPECIFIC RESTRICTION ENZYME DIGESTION [J].
GENG, J ;
STROBEL, HW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 197 (03) :1179-1184
[6]  
GENG J, 1995, J NEUROCHEM, V65, P554
[7]  
GONZALEZ F J, 1988, Genomics, V2, P174, DOI 10.1016/0888-7543(88)90100-0
[8]   CHARACTERIZATION OF THE COMMON GENETIC-DEFECT IN HUMANS DEFICIENT IN DEBRISOQUINE METABOLISM [J].
GONZALEZ, FJ ;
SKODA, RC ;
KIMURA, S ;
UMENO, M ;
ZANGER, UM ;
NEBERT, DW ;
GELBOIN, HV ;
HARDWICK, JP ;
MEYER, UA .
NATURE, 1988, 331 (6155) :442-446
[9]   A UNIQUE AROMATASE (P-450AROM) MESSENGER-RNA FORMED BY ALTERNATIVE USE OF TISSUE-SPECIFIC EXONS-1 IN HUMAN SKIN FIBROBLASTS [J].
HARADA, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 189 (02) :1001-1007
[10]   EXPRESSION ANALYSIS OF THE MIXED-FUNCTION OXIDASE SYSTEM IN RAT-BRAIN BY THE POLYMERASE CHAIN-REACTION [J].
HODGSON, AV ;
WHITE, TB ;
WHITE, JW ;
STROBEL, HW .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1993, 120 (02) :171-179